Survivorship: sexual dysfunction (male), version 1.2013.

Crystal S. Denlinger, Robert W. Carlson, Madhuri Are, K. Scott Baker, Elizabeth Davis, Stephen B. Edge, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Elizabeth Kvale, Terry S. Langbaum, Jennifer A. Ligibel, Mary S. McCabe, Kevin T. McVary, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Tracey O'ConnorElectra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole McMillian, Deborah Freedman-Cass, comprehensive cancer network National comprehensive cancer network

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Various anticancer treatments, especially those directed toward the pelvis, can damage blood vessels and reduce circulation of blood to the penis and/or damage the autonomic nervous system, resulting in higher rates of erectile dysfunction in survivors than in the general population. In addition, hormonal therapy can contribute to sexual problems, as can depression and anxiety, which are common in cancer survivors. This section of the NCCN Guidelines for Survivorship provides screening, evaluation, and treatment recommendations for male sexual problems, namely erectile dysfunction.

Original languageEnglish (US)
Pages (from-to)356-363
Number of pages8
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume12
Issue number3
DOIs
StatePublished - Mar 1 2014

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Survivorship: sexual dysfunction (male), version 1.2013.'. Together they form a unique fingerprint.

Cite this